For: | Wang LF, Chen PR, He SK, Duan SH, Zhang Y. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review. World J Gastroenterol 2023; 29(29): 4481-4498 [PMID: 37621757 DOI: 10.3748/wjg.v29.i29.4481] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v29/i29/4481.htm |
Number | Citing Articles |
1 |
Moushira Zaki, Hisham A. Orban, Marwa Mahmoud, Eman R. Youness, Hoda F. Booles, Wagdy K. B. Khalil, Wafaa Wafy, Kamal A. El-Atrebi, Khaled Hamed, Hala T. El-Bassyouni. Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-α as a marker of disease severity. Egyptian Journal of Medical Human Genetics 2024; 25(1) doi: 10.1186/s43042-024-00533-2
|
2 |
Yue Yang, Kan-Zuo Fu, Gu Pan. Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis. World Journal of Gastrointestinal Surgery 2024; 16(1): 228-238 doi: 10.4240/wjgs.v16.i1.228
Abstract(260) |
Core Tip(282) |
Full Article(HTML)(869)
|
Full Article with Cover (PDF)-3312K(41)
|
Full Article (Word)-1272K(13)
|
Audio-338K(3)
|
Peer-Review Report-177K(32)
|
Answering Reviewers-115K(31)
|
Supplementary Material-213K(33)
|
Full Article (PDF)-3033K(66)
|
Full Article (XML)-117K(29)
|
Times Cited (4)
|
Total Visits (2960)
|
Open
|
3 |
Nikil Vootukuru, Abhinav Vasudevan. Approach to loss of response to advanced therapies in inflammatory bowel disease. World Journal of Gastroenterology 2024; 30(22): 2902-2919 doi: 10.3748/wjg.v30.i22.2902
|